HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study ; volume:20 ; number:1 ; day:2 ; month:1 ; year:2020 ; pages:1-10 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (2.1.2020), 1-10, 12.2020
- Creator
-
Desta, Abraham Aregay
Woldearegay, Tewolde Wubayehu
Futwi, Nesredin
Gebrehiwot, Gebrecherkos Teame
Gebru, Goyitom Gebremedhn
Berhe, Asfawosen Aregay
Godefay, Hagos
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-019-4732-6
- URN
-
urn:nbn:de:101:1-2020041123061775541639
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Desta, Abraham Aregay
- Woldearegay, Tewolde Wubayehu
- Futwi, Nesredin
- Gebrehiwot, Gebrecherkos Teame
- Gebru, Goyitom Gebremedhn
- Berhe, Asfawosen Aregay
- Godefay, Hagos
- SpringerLink (Online service)
Other Objects (12)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
HIV virological non-suppression is highly prevalent among 18- to 24-year-old youths on antiretroviral therapy at the Kenyan coast
Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study
Ethiopia : violent suppression of student protest
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
The impact of community health worker-led home delivery of antiretroviral therapy on virological suppression: a non-inferiority cluster-randomized health systems trial in Dar es Salaam, Tanzania
A therapeutic hepatitis B mRNA vaccine with strong immunogenicity and persistent virological suppression